JSM 2011 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.


652 *	Thu, 8/4/2011, 10:30 AM - 12:20 PM	CC-A205
Decisionmaking in Drug Development Using Modeling and Simulation — Topic Contributed Papers
Biopharmaceutical Section
Organizer(s): Yi Liu, Millennium: The Takeda Oncology Company
Chair(s): Mingxiu Hu, Millennium: The Takeda Oncology Company
10:35 AM	Prediction of Phase III Survival Outcomes Using Phase II Surrogate Marker Results Through Modeling and Simulation — Yi Liu, Millennium: The Takeda Oncology Company ; Mingxiu Hu, Millennium: The Takeda Oncology Company ; Shan Yang, Iowa State University ; Guohui Liu, Millennium: The Takeda Oncology Company ; Hongliang Shi, Millennium: The Takeda Oncology Company
10:55 AM	Enabling Phase III Go/No-Go Decision Using Phase I/II Study Data — Jiang Qian, Abbott Laboratories ; Ya-Hui Hsu, Abbott Laboratories
11:15 AM	Assessment of Dosing Strategies for Anticancer Drugs via Nonlinear Mixed Model — Guohui Liu, Millennium: The Takeda Oncology Company ; Xuedong Chi, Millennium Pharmaceuticals
11:35 AM	Two Examples on the Use of Simulations to Guide Model Selections in MMRM Analyses — Peiling Yang, U.S. Food and Drug Administration ; Phillip Dinh, U.S. Food and Drug Administration
11:55 PM	Floor Discussion

2011 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.